Within the last few years, many studies have focused on the association between BRCA2 gene polymorphisms and cancer risk, including breast cancer, ovarian cancer, non-Hodgkin lymphoma, prostate cancer and others [13–18]. This evidence concerns the gene BRCA2 and cancer.